Method of treatment and devices for the treatment of left ventricular failure

• US 20080300677A1
• Filed: 10/19/2007
• Published: 12/04/2008
• Est. Priority Date: 10/01/2004
• Status: Abandoned Application

• Current Assignee: Howard L. Schrayer
• Original Assignee: Howard L. Schrayer
• Inventors: Schrayer, Howard L.
• Application Number:
  US11/975,567
• Publication Number:
  US 20080300677A1
• Time in Patent Office: Days
• US Class Current: 623/2.12
• CPC Class Codes: A61B 2017/22001 Angioplasty, e.g. PCTA
• CPC Class Codes: A61B 2017/22038 with a guide wire
• CPC Class Codes: A61F 2/2412 with soft flexible valve members, e.g. tissue valves shaped like natural valves check valves with flexible valve members in general F16K15/14
• CPC Class Codes: A61F 2/2475 Venous valves
• CPC Class Codes: A61F 2250/0059 temporary
• CPC Class Codes: A61M 29/02 Dilators made of swellable material balloon catheters for angioplasty A61M25/104

Abstract

The effects of acute left ventricular heart failure are mitigated by temporary support of the cardiac function through use of either one or both of an expendable temporary one-way valve positioned in the aorta, having a collapsible frame that is expanded upon deployment, and/or a temporary dilation device positioned in the descending aorta for expanding upon deployment to increase the diameter of the associated portion of the aorta. When used together, the dilation device is positioned distal to the temporary one-way valve.

Claims

1. (canceled)

2. (canceled)

3. (canceled)

4. (canceled)

5. (canceled)

6. (canceled)

7. (canceled)

8. (canceled)

9. Apparatus for jointly providing intravascular treatment of acute left ventricular heart failure comprising:

a) a collapsible temporary valve assembly including means for deploying it into the aorta via its introduction into the vascular system using percutaneous transluminal techniques, and means for both expanding and deploying it in the aorta; and

b) a collapsible vessel dilation assembly including means for deploying it into the aorta or peripheral arteries via its introduction into the vascular system using percutaneous transluminal techniques, and means for both expanding its diameter and deploying it in the aorta or peripheral arteries.

10. A device for the intravascular treatment of acute left ventricular heart failure comprising:

a collapsible temporary valve assembly including means for deploying it into the aorta via its introduction into the vascular system using percutaneous transluminal techniques, and means for both expanding and deploying it in the aorta.

11. A device for the intravascular treatment of acute left ventricular heart failure comprising:

a collapsible vessel dilation assembly including means for deploying it into the aorta or peripheral arteries via its introduction into the vascular system using percutaneous transluminal techniques, and means for both expanding its diameter and deploying it in the aorta or peripheral arteries.

12. A collapsible temporary valve assembly for deployment into the aorta via introduction into the vascular system using percutaneous transluminal techniques comprising:

a collapsible frame having at least three wires or bands joined at least at one end and biased radially outward so as to form a generally conic or bulbous cage upon deployment;

a control element joined directly or indirectly to the collapsible frame members at their juncture at the apex of the frame and extending to a point outside of the body to allow expansion and collapse of the frame by alternately allowing advancement of the frame from a constraining catheter and retraction of the frame into the catheter, whereby upon expansion of the frame the valve assembly functions in series with a patient'"'"'s essential normal aortic valve, thereby allowing the temporary valve assembly to decrease the back pressure on the natural valve when both are closing during the diastolic phase of the cardiac cycle;

an annulus in the form of a flexible strand disposed within or around the frame in a plane perpendicular to the longitudinal axis of the frame in the deployed position or a fluid permeable mesh disc disposed within the frame in a similar plane; and

at least three thin, flexible, biocompatible leaflets attached at their fixed edges to the annular strand or the mesh disc and configured to permit central flow of blood during cardiac systole and to substantially prevent retrograde flow of blood during cardiac diastole.

13. The valve assembly of claim 12, further including:

remote sensing means for capturing physiological data including intra arterial pressure, cardiac output, pulse rate, and other desired data.